125475-12-9

Upstream product

• 1517-82-4 (1R,2S,5R,SS)-(-)-menthyl p-toluenesulfinate 
• 872-32-2 2-methyl-1H-pyrroline 

Downstream Products

• 125517-36-4 (8S,8aR,1'S,SS)-8-(1-hydroxybutyl)-1,2,3,5,6,7,8,8a-octahydro-8-<(4-methylphenyl)sulfinyl>indolizine 
• 125475-14-1 (8S,8aS,1'S,SS)-8-(1-hydroxybutyl)-1,2,3,5,6,7,8,8a-octahydro-8-<(4-methylphenyl)sulfinyl>indolizine 
• 125517-35-3 (8R,8aR,1'S,SS)-8-(1-hydroxybutyl)-1,2,3,5,6,7,8,8a-octahydro-8-<(4-methylphenyl)sulfinyl>indolizine 
• 125517-34-2 (8R,8aS,1'S,SS)-8-(1-hydroxybutyl)-1,2,3,5,6,7,8,8a-octahydro-8-<(4-methylphenyl)sulfinyl>indolizine 
• 33023-01-7 (+)-elaeokanine A 
• 33023-02-8 (-)-Elaeokanine B 
• 18881-13-5 (+)-coniceine 
• 125475-13-0 (8aS,SR)-1,2,3,5,6,7,8,8a-octahydro-8-<(4-methylphenyl)sulfinyl>indolizine 
• 125475-13-0 (8aR,SR)-1,2,3,5,6,7,8,8a-octahydro-8-<(4-methylphenyl)sulfinyl>indolizine 

Relevant academic research and scientific papers

Asymmetric Total Syntheses of Elaeokanines A and B via α-Sulfinyl Ketimine

α-Lithiated (+)-(R)-4,5-dihydro-2-methyl>-3H-pyrrole (4) underwent annulation with 1,3-diiodopropane to give (-)-(S,S)-1,2,3,5,6,7-hexahydro-8-indolizine (6), which was converted into (-)-elaeokanine B (three steps) and (+)-elaeokanine A (four steps).